Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Fifth Disease by Superinfection of Parvovirus B19 in a 7-Year-Old Boy with Hemolytic Uremic Syndrome
저자 Se Jin Park1, Ki Soo Pai1, Jae Il Shin2
출판정보 2015; 2015(1):
키워드 용혈성 요독 증후군,파보바이러스,제5병
초록 Hemolytic Uremic Syndrome (HUS) is defined by the occurrence of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. It is one of the main causes of acute kidney injury in children. HUS is divided into two types: typical and atypical HUS. Atypical HUS is known as a disease related to genetic mutations in the alternative complement pathway and has a distinct pathophysiology, whereas typical HUS is resulted from Shiga or Shiga-like toxin-producing Escherichia coli (STEC) and Shigella dysenteriae type 1 infection. Human parvovirus B19 (PVB19) belongs to the Erythroparvovirus genus within the Parvoviridae family. PVB19 is the predominant parvovirus pathogen in humans, and as such, B19 is the prototype strain for genotype 1. PVB19 infection is usually asymptomatic, but it can cause the childhood rash called fifth disease or erythema infectiosum, or “slapped cheek syndrome” in healthy individual and aplastic crisis in patients with hematological disorder, such as congenital or acquired hemolytic anemia. PVB19 infects proerythroblast via P-antigen, inhibits erythropoiesis, makes short life-span of erythrocytes, and causes severe anemia in patients with underlying hematological disorders. PVB19 also induces thrombotic microangiopathy of kidney and suppression of megakaryocyte. We present a case of a 7-year-old boy who initially presented with fever, skin rash, petechiae, headache, and vomiting. His transient febrile episode and skin rash were proven to be associated with parvovirus B19. Evaluation resulted in our impression of the disease being HUS with superinfection of PVB19 or possibly induced by PVB19.
원문(PDF) PDF 원문보기
위로가기